participant flow for clinicaltrials:NCT00122980 [clinicaltrials_resource:cac5e5ccb559aafd409d2073d19ad0a2]
participant flow [clinicaltrials_vocabulary:participant-flow]
participant flow for clinicaltrials:NCT00122980 [clinicaltrials_resource:cac5e5ccb559aafd409d2073d19ad0a2]
Bio2RDF identifier
cac5e5ccb559aafd409d2073d19ad0a2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cac5e5ccb559aafd409d2073d19ad0a2
group [clinicaltrials_vocabulary:group]
period [clinicaltrials_vocabulary:period]
pre assignment details [clinicaltrials_vocabulary:pre-assignment-details]
Participant qualification was ...... esults prior to randomization.
recruitment details [clinicaltrials_vocabulary:recruitment-details]
Phase III First Patient In: 31 ...... the United States of America.
identifier
clinicaltrials_resource:cac5e5ccb559aafd409d2073d19ad0a2
title
participant flow for clinicaltrials:NCT00122980
@en
type
label
participant flow for clinicalt ...... 5e5ccb559aafd409d2073d19ad0a2]
@en